跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COVERSYL PLUS LD 2/0.625 tablet - TGA Drug Approval Details
Approvals
/
TGA
/
COVERSYL PLUS LD 2/0.625 tablet
Approved
STANDARD
COVERSYL PLUS LD 2/0.625 tablet
Servier Laboratories (Aust) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
fc6902ecc638458d
Company
Servier Laboratories (Aust) Pty Ltd
Type
Standard
Approval Details
Approval Id
fc6902ecc638458d
Product Name
COVERSYL PLUS LD 2/0.625 tablet
Artg Id
116473
Artg Name
COVERSYL PLUS LD 2mg/0.625mg perindopril erbumine / indapamide hemihydrate tablet blister pack
Sponsor
Servier Laboratories (Aust) Pty Ltd
Company Detail Path
/organization/servier-laboratories-aust-pty-ltd
Artg Date
2005-02-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
fc6902ecc638458d
Type
Standard
Back to TGA Approvals